All News

HIV patients whose antiretroviral therapy was initiated and managed by pharmacists achieved earlier viral suppression compared with those managed by a primary HIV clinician, according a report published in the September 1 issue of the American Journal of Health-System Pharmacy.

Sandoz announced that Zarxio (filgrastim-sndz), the first biosimilar approved by the FDA in March, is now available in the United States.

The state of Illinois will launch a pilot program next year to try to answer that question.

Kmart has agreed to pay $1.4 million to settle charges it used illegal inducements to encourage Medicare patients to forego generics for more expensive brand names.

FDA issued a warning this week that dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes may cause severe and disabling joint pain.

Guest columnist The Cynical Pharmacist offers a proposal every retail pharmacist will love.

More than 7 out of 10 Americans believe that drug costs are unreasonable and drug companies place profits before people, according to a recent Kaiser Health Tracking poll.

Florida’s crackdown on pill mills has resulted in decreases in opioid prescriptions, according to an online study published by JAMA Internal Medicine.

While the rate of new drug shortages has fallen, manufacturing problems and FDA import bans continue to cause shortages of certain medications in U.S. hospitals.

The U.S. Department of Health and Human Services has awarded an $8.3 million grant to Xavier University (XU) of Louisiana College of Pharmacy to recruit underrepresented minority students and faculty members.

Now that a judge has granted conditional class certification to a lawsuit claiming Walmart failed to compensate pharmacists for some time related to immunization training, the lead plaintiff is urging her former colleagues to join the litigation.

Here's more of what blew up Dennis Miller's mailbox.

Supermarket pharmacies averaged the highest customer-satisfaction scores in J.D. Power’s “2015 U.S. Pharmacy Study."

A Miami pharmacist recently pled guilty to charges she stole the identifying information of Medicare beneficiaries and then submitted fraudulent claims on their behalf.

Walmart is blaming lower margins in its pharmacy business for holding down overall corporate profits.

By joining together with other hospitals on medication purchasing and other efforts, Kalispell Regional Medical Center in Kalispell, Mt., has saved millions of dollars annually.

CVS Health recently introduced a new pharmacy service, ScriptSync, designed to enable patients with multiple Rxs to pick them up during one visit to the pharmacy.

Walgreens has agreed to pay $502,200 to settle charges that some of its pharmacists in California failed to provide patient consultations required by law.

Pharmacists open up about the ones that haunt their dreams.

Drug shortages are forcing hospitals to turn to compounded meds. It's time to develop a nationally recognized certification program for the practice of sterile compounding.

Patients with poorly controlled type 2 diabetes (T2DM) experienced a significant decline in their HbA1c levels when adding Technosphere inhaled insulin (Afrezza, MannKind Corp.) to their current treatment regimen, according to a new study.

U.S. District Court Judge Mark Kearney recently dismissed the class-action lawsuit of a Pennsylvania pharmacist who claimed CVS failed to pay him overtime pay.

The future of community pharmacy is a high-tech, connected world, where teleprescribing is common and pharmacists share information with patients via smart lenses.

Richmond University Medical Center, Staten Island, N.Y., recently opened the first fully-functioning retail pharmacy in a hospital in the area.

CVS/Caremark and Express Scripts, the two biggest players in the pharmacy benefits management industry, have both added medications to their exclusion lists.

Independent community pharmacists found plenty to think about at the recent McKesson ideaShare Conference in San Diego.

Natpara is indicated only as adjunctive therapy to calcium and vitamin D supplementation and is available only through a restricted REMS program.

Three community pharmacy professionals share their top tips on what makes pharmacists successful managers.

Interchangeability means different things to different stakeholders. Here are some things they will need to agree on.

Canada, the E.U., South Korea, Japan, India, and Australia - all have had clear regulatory pathways in place for years. The United States has been working on a biosimilars pathway for almost a decade. What's different?